Xian Ping Lu
Chief Executive Officer bei SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Vermögen: 58 Mio $ am 31.03.2024
Profil
Xian Ping Lu is the founder of Shenzhen Chipscreen Biosciences Co., Ltd., where he currently holds the title of Chairman & General Manager since 2020.
He founded the company in 2001.
Dr. Lu is also the founder of Maxia Pharmaceuticals, Inc. Dr. Lu's former job was as a Research Director at Galderma Research & Development SNC.
Dr. Lu's education includes an undergraduate degree from Sichuan University in 1983, a graduate degree from Peking Union Medical College in 1986, and a doctorate degree from Peking Union Medical College in 1988.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.09.2023 | 22 239 625 ( 5,41% ) | 58 Mio $ | 31.03.2024 |
Aktive Positionen von Xian Ping Lu
Unternehmen | Position | Beginn |
---|---|---|
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Chief Executive Officer | 24.03.2018 |
Ehemalige bekannte Positionen von Xian Ping Lu
Unternehmen | Position | Ende |
---|---|---|
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - |
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The private company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Founder | - |
Ausbildung von Xian Ping Lu
Sichuan University | Undergraduate Degree |
Peking Union Medical College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The private company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |